Agios Pharmaceuticals, Inc. AGIO
$37.00
-0.51%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (5 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $41.50
- Implied Upside
- +12.2%
- Price Target Range
- $32.00 – $55.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-07 | Truist SecuritiesGregory Renza |
Maintains | Buy | $39 → $37 |
| 2026-09-21 | B of A SecuritiesAlec Stranahan |
Maintains | Buy | $46 → $50 |
| 2026-08-07 | JP MorganTessa Romero |
Maintains | Neutral | $31 → $34 |
| 2026-07-31 | CitigroupSamantha Semenkow |
Maintains | Buy | $46 → $52 |
| 2026-07-31 | Truist SecuritiesGregory Renza |
Maintains | Buy | $41 → $39 |
| 2026-07-30 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $52 → $55 |
| 2026-07-21 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $50 → $52 |
| 2026-07-07 | RBC CapitalLuca Issi |
Maintains | Sector perform | $28 → $32 |
| 2026-07-07 | Truist SecuritiesGregory Renza |
Maintains | Buy | $36 → $41 |
| 2026-07-07 | B of A SecuritiesAlec Stranahan |
Maintains | Buy | $40 → $46 |
| 2026-06-11 | JP MorganTessa Romero |
Maintains | Neutral | $36 → $31 |
| 2026-05-29 | B of A SecuritiesGreg Harrison |
Maintains | Buy | $41 → $40 |
| 2026-04-30 | Truist SecuritiesGregory Renza |
Maintains | Buy | $39 → $36 |
| 2026-04-21 | B of A SecuritiesGreg Harrison |
Maintains | Buy | $44 → $41 |
| 2026-04-20 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $65 → $50 |
| 2026-04-06 | JP MorganTessa Romero |
Maintains | Neutral | $31 → $36 |
| 2026-04-01 | Goldman SachsSalveen Richter |
Maintains | Neutral | $28 → $32 |
| 2026-03-05 | CitigroupSamantha Semenkow |
Maintains | Buy | $38 → $46 |
| 2026-02-12 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $62 → $65 |
| 2026-01-06 | JP MorganTessa Romero |
Maintains | Neutral | $20 → $25 |
| 2025-12-26 | Leerink PartnersAndrew Berens |
Maintains | Outperform | $34 → $40 |
| 2025-12-24 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $48 → $62 |
| 2025-12-24 | Truist SecuritiesGregory Renza |
Maintains | Buy | $32 → $38 |
| 2025-12-24 | B of A SecuritiesGreg Harrison |
Maintains | Buy | $32 → $34 |
| 2025-11-26 | CitigroupSamantha Semenkow |
Initiates coverage on | Buy | $38 |
| 2025-11-24 | Truist SecuritiesGregory Renza |
Initiates coverage on | Buy | $32 |
| 2025-11-21 | JP MorganTessa Romero |
Maintains | Neutral | $37 → $20 |
| 2025-11-20 | RBC CapitalLuca Issi |
Downgrades | Outperform → Sector perform | $57 → $28 |
| 2025-11-20 | B of A SecuritiesGreg Harrison |
Maintains | Buy | $54 → $32 |
| 2025-11-20 | Leerink PartnersAndrew Berens |
Upgrades | Market perform → Outperform | $40 → $34 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $37.00
- Market Cap
- $2.21 billion
- 52-Week Range
- $22.24 – $46.00
- Average Volume
- 1.17 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.